Incentive plans for drug makers who highly national contributed.

Published: 2006-04-19 06:56:00

Updated: 2006-04-19 06:56:00

"To save the NHI finance the government should reflect the nation's contribution of the pharmaceutical company in the diverse drug pricing determination policies including the adoption of a positive NHI drug pricing system" said by Dr. Lee Hee-gyeong of Korea Institute for Health and Social Affai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK